featured
2024 Top Story in Eye Care: Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Wai KM, Mishra K, Koo E, et al. Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study. Am J Ophthalmol. 2024;265:39–47.
- Cheung N, Mitchell P, Wong TY. Diabetic Retinopathy. Lancet. 2010;376(9735):124–136.
- Nathan DM, Genuth S, Lachin J, et al. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N Engl J Med. 1993;329(14):977–986.
- Diabetes Control and Complications Trial Research Group. Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998;116(7):874–886.
- Dai ZC, Chen JX, Zou R, et al. Role and Mechanisms of SGLT-2 Inhibitors in the Treatment of Diabetic Kidney Disease. Front Immunol. 2023;14:1213473.
- Gupta M, Rao IR, Nagaraju SP, et al. Diabetic Retinopathy Is a Predictor of Progression of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis. Int J Nephrol. 2022;2022:3922398.